Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO (@tomleblancmd) 's Twitter Profile
Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO

@tomleblancmd

Patient experience & cancer outcomes researcher | Leukemia & palliative care doc | Chief PX and Safety Officer @DukeCancer | #ASCO24 Ed Chair. Tweets mine.

ID: 519626254

linkhttps://medicine.duke.edu/faculty/thomas-william-leblanc-md calendar_today09-03-2012 16:39:15

9,9K Tweet

4,4K Followers

1,1K Following

Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO (@tomleblancmd) 's Twitter Profile Photo

Practice-changing findings from the STEP-PC trial: "stepped" #palliativecare yields meaningful benefits for patients with advanced #lungcancer, with fewer visits overall! It achieves this by right-sizing the frequency of PC visits based upon each patient's symptom/QoL needs over

Practice-changing findings from the STEP-PC trial: "stepped" #palliativecare yields meaningful benefits for patients with advanced #lungcancer, with fewer visits overall! It achieves this by right-sizing the frequency of PC visits based upon each patient's symptom/QoL needs over